Loading AI tools
Berlin-Chemie Menarini is a German-Italian pharmaceutical company based in Berlin, Germany, and Florence, Italy. The company was formed in 1992 by the merger of the German company Berlin-Chemie and Italian company Menarini.
 | You can help expand this article with text translated from the corresponding article in German. (September 2019) Click [show] for important translation instructions.
|
 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceutical industry |
| Founded | 1890 |
| Headquarters | |
Key people | Luca Lastrucci (Chairman of the Executive Board) Edward Szybowski Christian Matschke Attilio Sebastio Christiane von der Eltz Ivan Bergstein |
| Revenue | 1.5 billion EUR (2021)[1] |
| Owner | Menarini Group |
Number of employees | 5,000 (2021)[1] |
| Website | www.berlin-chemie.com |
Berlin-Chemie considers the establishment of a plant for the laboratory preparations of the Chemical factory of Kahlbaum in Berlin-Adlershof in 1890, as its origin.[2] The first factory located in the former administrative district of Treptow, Berlin-Adlershof.[3] In 1927 after the merger with Schering AG employees began the development of drugs. After the end of the Second World War, the Adlershof factory of Schering AG was located in the Soviet occupation zone and thus in the later German Democratic Republic. From the mid-50s onwards, the company signed as VEB Berlin-Chemie. When the state-owned companies were privatized or dissolved after the political turnaround, the Italian group Menarini took over the factory in Berlin in 1992, including the product name, and thus immediately found a larger sales market in Eastern Europe.[4]
In February 2013, Berlin-Chemie took over the Priligy brand, a drug against premature ejaculation. Since mid-2013, there has been a media campaign on the internet and through posters on the subject of premature ejaculation, which many physicians are critical of. According to the imprint of the website in question, Later Come.de, this is a media contribution by Berlin-Chemie AG.[5]
Since 2015, Berlin-Chemie has been able to manufacture and sell anti-cancer drugs through a license agreement with the Japanese drug manufacturer Chugai.[6]
The production of infusion solutions was discontinued in 2019.
In 2023, the World Intellectual Property Organization (WIPO)’s Madrid Yearly Review ranked Berlin Chemie's number of marks applications filled under the Madrid System as 6st in the world, with 107 trademarks applications submitted during 2023.[7]
Wikiwand in your browser!
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.
